4/A

FORM 4/A SUBMISSION

Company: NEKTAR THERAPEUTICS
Filed: September 25, 2020
Period of Report: September 22, 2020
Accession Number: 0001209191-20-052155

View Document ↗ View on SEC.gov ↗